Table of Contents Table of Contents
Previous Page  51 / 68 Next Page
Information
Show Menu
Previous Page 51 / 68 Next Page
Page Background

Radiation Oncology

Volume 12 No 4

I

September 2016

51

Dr Dion Forstner

I feel privileged to have been elected to

serve the Faculty of Radiation Oncology

as the Dean for another two-year term

from January 2017 to December 2018. I

appreciate the confidence and trust from

the College Board and Faculty Council,

and would like to take this opportunity

to thank all Council members, College

staff, and my wonderful colleagues at

Liverpool Hospital for their hard work

and support during my current term.

We have made a great deal of progress

in the last two years towards achieving

the strategic priorities of the Faculty, in

particular in the area of advocacy and

government engagement. We have

established a sound and collaborative

relationship with the Department

of Health which is extremely helpful

during this critical time when both the

Medicare Benefits Schedule (MBS) and

the Radiation Oncology Health Program

Grants (ROHPG) are being reviewed.

While we celebrate our achievements,

we also acknowledge various issues

and challenges ahead, e.g. ongoing

work around the MBS/ROHPG reviews,

ongoing workforce issues, progressing

the radiation oncology practice

standards, how to best support the

Faculty standing committees and

special interest groups and ultimately

strengthening the voice of radiation

oncology within the health sector both

in Australia and New Zealand. The

Faculty Council and I are committed to

addressing these issues, continuously

improving the radiation oncology sector

and ensuring that we identify new

challenges and opportunities early.

We welcome suggestions and ideas from

all radiation oncology members, and I

encourage all of you to get involved in

College activities, which is guaranteed to

be a rewarding experience.

Profile and Presence of Radiation

Oncology

The Targeting Cancer campaign

continues to make progress in various

areas, including GP education, media/

social media presence, website

development, etc.

It is very exciting that the Targeting

Cancer website recently won the Best in

Class Award in the healthcare category

of the Interactive Media Awards, as well

as a gold medal in the 2016 Sydney

Design Awards. Please see the article on

page 23 for more details.

I congratulate the Targeting Cancer team

on this outstanding achievement and

encourage all members to participate in

Targeting Cancer activities.

Please contact

faculty@ranzcr.edu.au

if

you are interested in getting involved, to

help raise the profile of our profession,

and ultimately increase the utilisation

rate of radiation therapy.

Funding of Radiation Therapy

The review of the radiation oncology

items within the MBS is well underway.

The first activity of the Oncology Clinical

Committee (OCC) was to look at

obsolete items within the schedule. The

Faculty’s MBS Review Working Group

consulted with heads of departments on

the list of items identified as potentially

obsolete and provided advice to the

nominees on the OCC: Dr Liz Kenny, Prof

Michael Barton and A/Prof Chris Milross.

The radiation oncology section of the

MBS is outdated and does not reflect the

way we currently deliver treatment to our

patients. Through our working group,

the Faculty is providing advice to the

OCC nominees on various options for

redesigning the schedule to better suit

contemporary practice.

We continue to seek opportunities to

nominate Fellows to other committees

of the MBS Review that intersect with our

specialty. Prof Gill Duchesne has been

nominated to the Nuclear Medicine

Working Group which has been formed

under the Diagnostic Imaging Clinical

Committee.

Updated Faculty Guidelines for

Informed Consent with Informed

Financial Consent

In 2010, the Faculty published Guidelines

for Informed Consent, which represent

the Faculty’s view on the pivotal matter

of patient consent to receive radiation

treatment.

The Faculty Council believes it is

important for patients to understand the

costs associated with radiation oncology

services, and full disclosure of financial/

cost information should be provided in

writing to patients before they sign the

informed consent form.

The Faculty Council recently approved

updates to the guidelines for informed

consent, which now include a section on

A Message

from the Dean